ADORA2A and epilepsy: This newly identified selective role of A2AR in the control of the neurodegeneration that develops as a consequence but after the convulsive period (Sperk et al., 1983; Pitkänen and Sutula, 2002) heralds the concepts of A2AR blockade as a new therapeutic strategy to arrest the evolution of epilepsy.